Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Olmesartan: 360-degree Perspectives Befitting an Angiotensin Receptor Blocker.
Shetty S, Bhoraskar A, Saboo B, Routray S, Tiwaskar M, Sreenivasamurthy L, Shrivas VK, Jose A, Prajapati C, Qamra A, Muralidharan P. Shetty S, et al. Among authors: sreenivasamurthy l. J Assoc Physicians India. 2024 Dec;72(12):59-72. doi: 10.59556/japi.72.0780. J Assoc Physicians India. 2024. PMID: 39676196 Review.
Position statement on hypertension by Indian Society of Hypertension, 2023.
Maheshwari A, Gupta R, Verma N, Narasingan SN, Singh RB, Saboo B, Kumar CHV, Gupta A, Srivastava MK, Gupta A, Srivastava S, Aggarwal A, Tewari A, Ansari S, Patni B, Agarwal D, Sattur GB, Rodrigues L, Pareek KK, Yeolekar M, Banerjee S, Sreenivasamurthy L, Das MK, Joshi S, Vajpeyee S, Muthusamy VV, Muruganathan A. Maheshwari A, et al. Among authors: sreenivasamurthy l. J Hum Hypertens. 2024 Nov;38(11):736-744. doi: 10.1038/s41371-024-00960-z. Epub 2024 Oct 4. J Hum Hypertens. 2024. PMID: 39367179
Responsible Use of Oral Corticosteroids in People with Comorbid Diabetes: An Expert Consensus.
Saboo B, Joshi S, Gupta A, Maheshwari A, Saboo B, Makkar BM, Bantwal G, Kesavadev J, Sreenivasamurthy L, Tiwaskar M, Chawla M, Shunmugavelu M, Singh NK, Jethwani P, Agarwal S, Gupta S, Swarnakar R, Sahay R, Vishwanathan V, Prajapati C, Qamra A, Muralidharan P. Saboo B, et al. Among authors: sreenivasamurthy l. J Assoc Physicians India. 2024 Jul;72(7):79-93. doi: 10.59556/japi.72.0573. J Assoc Physicians India. 2024. PMID: 38990592 Review.
Association of Physicians of India Expert Recommendations on Oral Fluid, Electrolytes, and Energy Management during Transition Care and Discharge for Hospitalized Patients with Nondiarrheal Illnesses.
Reddy BR, Sreenivasamurthy L, Pal J, Saseedharan S, Sathe P, Maheshwari A, Canday E, Hazarika BG, Patil A, Malve H, Thakor P. Reddy BR, et al. Among authors: sreenivasamurthy l. J Assoc Physicians India. 2024 Jun;72(6S):57-66. doi: 10.59556/japi.72.0571. J Assoc Physicians India. 2024. PMID: 38932735
Comparison of the efficacy, safety, and tolerability of the FDC of telmisartan + bisoprolol with telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: A double-blind, multicentric, phase-III clinical study.
Wander GS, Ram B, Kumar Sonkar S, Manjunath CN, Kamath P, Sreenivasamurthy L, Balamurugan R, Narasinga Rao S, Roy D, Vipulkumar Bachubhai P, S M, Kumar M K. Wander GS, et al. Among authors: sreenivasamurthy l. Indian Heart J. 2024 May-Jun;76(3):159-166. doi: 10.1016/j.ihj.2024.06.002. Epub 2024 Jun 12. Indian Heart J. 2024. PMID: 38871219 Free PMC article. Clinical Trial.
Pre-Basal Insulin Analog Era: Paving the Way for Modern Day Basal Insulins.
Tiwaskar M, Deb P, Khadgawat R, Sreenivasamurthy L, Deka N, Karthik B, Karuppan A, Bhattacharjee D, Mohan V. Tiwaskar M, et al. Among authors: sreenivasamurthy l. J Assoc Physicians India. 2020 Dec;68(12[Special]):9-12. J Assoc Physicians India. 2020. PMID: 33247657 Review.
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Free article. Clinical Trial.
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.
Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P, Køber LV, Lawson F, Lewis EF, Maggioni AP, McMurray JJ, Ping L, Probstfield JL, Solomon SD, Tardif JC, Wu Y, Pfeffer MA; ELIXA Investigators. Bentley-Lewis R, et al. Am Heart J. 2015 May;169(5):631-638.e7. doi: 10.1016/j.ahj.2015.02.002. Epub 2015 Feb 12. Am Heart J. 2015. PMID: 25965710 Free article. Clinical Trial.